Featured Insight
Access90: Inflation Reduction Act Insights Series – Patient Affordability: A Key Question Answered
Will the Inflation Reduction Act actually increase drug affordability? Well…it’s complicated. RyanCox, VP, Director, PRECISIONvalue Access Experience Team, outlines the ways it will cut costs—and some watchouts. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
Access90: Inflation Reduction Act Insights Series – Patient Affordability: A Key Question Answered
Will the Inflation Reduction Act actually increase drug affordability? Well…it’s complicated. RyanCox, VP, Director, PRECISIONvalue Access Experience Team, outlines the ways it will cut costs—and some watchouts. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
On-Demand Webinar – SDOH and EHR – How are EHR vendors enabling providers’ efforts to close care gaps attributable to SDOH?
In this 1 hour live webinar, Precision experts Thad Nowakowski, Tim Van Aken, and Maureen Hennessey discuss the role that Social Determinants of Health plays in contributing to care gaps, current or proposed quality measures to support health equity, and how the top EHR vendors are enabling end user’s efforts to both capture SDOH variables, and act upon them to close care gaps.
On-Demand Webinar – Trends in Oncology: US Payer Management Considerations for 2022 and Beyond
In the last five years, 83 novel oncology substances have launched - oncology PMPM spend is now the highest among medical benefit categories, with 105% growth anticipated by 2024. As these numbers suggest, oncology is a key area of focus for payers, who are willing to invest resources to support appropriate utilization, but who struggle to keep up with the rapidly evolving science.
On-Demand Webinar – A Novel Data and Analytics-Informed Approach to Launch Excellence
Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.
A Focus on the Inflation Reduction Act
Curious how the healthcare provisions in the Inflation Reduction Act will impact your business? Start with this booklet by key experts from PRECISIONvalue where 5 experts weigh in on how the Inflation Reduction Act will affect payers in addition to 2023 trends, events, and developments in the payer world. Download the booklet.
White Paper: Achieving Launch Excellence: A Novel Data- and Analytics-Informed Approach
Data and analytics can help drive and inform launch preparations and support efforts to achieve launch excellence through realistic goal-setting and risk mitigation. PRECISIONadvisors works with manufacturers, helping them make key decisions—related to product positioning, go-to-market strategy, and customer engagement across payers, providers, prescribers, and patients—through data- and analytics-driven insights. Learn how an integrated data-driven approach can set realistic goals and de-risk your launch.
White Paper: 2022 and Beyond: How Key Legislative Events Will Impact the Payer Landscape
Interested in learning more about several legislative events shaping the managed care landscape in 2022 and beyond? Check out this insightful white paper, based on our recent webinar, which features insights from PRECISIONvalue’s expert Access Experience Team on various legislative proposals and payers’ potential responses to regulatory changes.
Download Now: Precision October Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision September Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision June Events Calendar
The June Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
EP11 How to Build a Snowball with Mike Chambers
The Blind Spot With Deb Seymour speaks with Precision's Mike Chambers about sales performance. Imagine working for a company that has trust & culture at its core. Teams collaborate, ideas are tested without fear of failure and respect and engagement help bring people to the "game" with a 100% committed attitude.
Looking Forward to 2022, COVID-19 Will Continue to Impact Pharma in Myriad Ways
Moving into 2022, the COVID pandemic unfortunately continues to dominate headlines. However, it’s not all bad news. AIS Health spoke with a variety of industry experts, including Precision's Cynthia Miller and Reta Mourad, about the myriad ways COVID-19 will continue to impact pharma this year and beyond.
New PBM players banking on drug pricing transparency for success
Two new pharmacy benefit managers (PBMs), the Cost Plus Drug Company and PBGH, are looking to promote drug pricing transparency, which larger PBMs have been reluctant to do. Precision's Cynthia Miller and Reta Mourad discuss the companies' markedly different business models to lower drug prices and the challenges that lie ahead.
Mandatory Value-based Care Payment Models on the Horizon
To get healthcare costs under control and “bend the cost curve,” the Centers for Medicare & Medicaid Services is moving from a volume-based reimbursement model to one based on value. To that end, the Center for Medicare & Medicaid Innovation has developed over a dozen new voluntary and mandatory value-based payment models.
Cancer Care in the Misinformation Age
While misinformation has plagued the public health field for decades, social media has amplified its spread. Both medical and public health leaders are beginning to develop strategies for this public health crisis. Precision's Cynthia Miller lists three ways pharma companies can work with stakeholders to address cancer misinformation using evidence-based approaches.
White Paper: The Evolving Role of Care Management
Care management is a broad term often encompassing disease management, case management, and utilization management functions. The need for strong care management capabilities is fundamental to the success of value-based care, team-based care, and population health management.
Value Transformation: Observations on Performance Periods 1-5 Evaluation Report of the Oncology Care Model
The Centers for Medicare & Medicaid Services (CMS) announced another evaluation report of the Oncology Care Model (OCM) in January 2021, covering activities and results for performance periods 1 through 5 of 11. Precision's Maureen Hennessey and Elizabeth Oyekan analyze what we've learned so far as they review the key findings and observations of performance periods 1 through 5.
MM&M’s Top 100 North American healthcare agencies of 2021
We are happy to announce that PRECISIONvalue has made the list of MM&M's Top 100 North American healthcare agencies of 2021!
Payers Create CAR-T Approval Systems as Adoption Increases
Spurred by CMS’s decision to cover CAR-T cell therapies under Medicare, commercial payers are beginning to systematize approvals for CAR-T treatment as use of these breakthrough cancer therapies is beginning to ramp up. Precision's Dan Danielson weighs in on factors driving authorizations now and what to expect as more CAR-T therapies are approved.
Epidemics Within the Pandemic: Shifting Priorities and Opportunities for Addressing Opioid and Mental Health Crises During Covid-19
A survey conducted by PRECISIONvalue of population health priorities among health systems and health plans since the onset of Covid-19 suggests that while mental health conditions have risen in priority, opioid use disorders have become alarmingly deprioritized. Precision's Maureen Hennessey shares the survey data and offers observations and suggestions for opportunities for plans, delivery systems, and pharmaceutical manufacturers to address the mental health and substance use epidemics occurring within the COVID pandemic.
Bending the Health Care Cost Curve and Changing the Drug Cost Paradigm in 2021 and Beyond
The continued rise in health care spending is having a profound effect on the US economy and health care payers. Efforts have largely focused on transformation of our health system payment model, by moving from fee-for-service to value-based care, and reducing the costs of prescription drugs, as a means of reducing health care costs. Precision's Elizabeth Oyekan and Andrew Cournoyer discuss why a multimodal, holistic approach is required to successfully tackle the issue of rising health care spending.
Med Ad News 2021 Healthcare Communications Agencies Edition: PRECISIONvalue Profile
PRECISIONvalue, a Vision Awards finalist, is profiled in the Med Ad News 2021 Healthcare Communications Agencies edition. Read here for great insights into how PRECISIONvalue adapted to the unique challenges of 2020, recent accomplishments (including a major rebranding, creation of a dedicated diversity and inclusion initiative, and recruitment and onboarding of high level talent) and future plans.
